Ashton Thomas Private Wealth, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Ashton Thomas Private Wealth, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$883.2 - $1071.19 $32,678 - $39,634	37 New	37 $38.9 Million
Q4 2021 Apr 19, 2024	SELL	$543.48 - $670.97 $1.14 Million - $1.41 Million	-2,102 Closed	0 $0
Q3 2021 Apr 19, 2024	BUY	$574.03 - $680.96 $105,047 - $124,615	183 Added 9.54%	2,102 $1.27 Billion
Q2 2021 Apr 19, 2024	BUY	$472.8 - $558.54 $18,439 - $21,783	39 Added 2.07%	1,919 $1.07 Billion
Q1 2021 Apr 19, 2024	BUY	$446.73 - $548.2 $116,596 - $143,080	261 Added 16.12%	1,880 $890 Million
Q4 2020 Apr 19, 2024	BUY	$478.3 - $607.98 $593,092 - $753,895	1,240 Added 327.18%	1,619 $782 Million
Q3 2020 Apr 19, 2024	BUY	$544.75 - $658.21 $27,237 - $32,910	50 Added 15.2%	379 $212 Million
Q2 2020 Apr 19, 2024	BUY	$493.32 - $643.92 $162,302 - $211,849	329 New	329 $205 Million

1,532

82.7M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $78.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Ashton Thomas Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Ashton Thomas Private Wealth, LLC with notifications on news.